Acellular pertussis vaccines

Current Problems in Pediatrics

Volumn 30, Issue 6, 2000, Pages 185-201

  Schleiss, Mark R ^a,b   Dahl, Karen ^a,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b CINCINNATI CHILDREN S HOSPITAL RESEARCH FOUNDATION   (United States)

^c UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACELLULAR VACCINE; PERTUSSIS VACCINE;

CHEMISTRY; CHILD; COMPARATIVE STUDY; FEMALE; HISTORY; HUMAN; INFANT; JAPAN; MALE; MICROBIOLOGY; PERTUSSIS; PRESCHOOL CHILD; REVIEW; SAFETY; STANDARD; TREATMENT OUTCOME; UNITED STATES;

CHEMISTRY, PHARMACEUTICAL; CHILD; CHILD, PRESCHOOL; CONSUMER PRODUCT SAFETY; FEMALE; HISTORY, 20TH CENTURY; HUMANS; INFANT; JAPAN; MALE; PERTUSSIS VACCINE; TREATMENT OUTCOME; UNITED STATES; VACCINES, ACELLULAR; WHOOPING COUGH;

EID: 0034223412     PISSN: 00459380     EISSN: None     Source Type: Journal    
DOI: 10.1067/mps.2000.107.834     Document Type: Article

References (18)

1. Bordet J, Gengou O. Le microbe de la coqueluche. Ann Inst Pasteur 1906;20:731-41.
2. Bergfors E, Trollfors B, Taranger J, Lagergard T, Sundh V, Zackrisson G. Parapertussis and pertussis: differences and similarities in incidence, clinical course, and antibody responses. Int J Infect Dis 1999;3:140-6.
3. Woolfrey BF, Moody JA. Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev 1991;4:243-55.
4. Kloos WE, Mohapatra N, Dobrogosz WJ, et al. Deoxyribonucleotide sequence relationships among Bordetella species. Int J Syst Bacteriol 1981;31:173-6.
5. Stibitz S, Garletts TL. Derivation of a physical map of the chromosome of Bordetella pertussis Tohama I. J Bacteriol 1992;174:7770-7.
6. Stibitz S, Yang MS. Genomic fluidity of Bordetella pertussis assessed by a new method for chromosomal mapping. J Bacteriol 1997;179:5820-6.
7. Stibitz S, Yang MS. Genomic plasticity in natural populations of Bordetella pertussis. J Bacteriol 1999;181:5512-5.
8. Pittman M. The concept of pertussis as a toxin-mediated disease. Pediatr Infect Dis J 1984;3:467-86.
9. Locht C, Keith JM. Pertussis toxin gene: nucleotide sequence and genetic organization. Science 1986;232:1258-64.
10. Nicosia A, Perugini M, Franzini C, et al. Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A 1986;83:4631-5.
11. Weiss AA, Hewlett EL. Virulence factors of Bordetella pertussis. Annu Rev Microbiol 1986;40:661-86.
12. Pizza M, Bugnoli M, Manetti R, et al. The subunit S1 is important for pertussis toxin secretion. J Biol Chem 1990;265:17759-63.
13. Domenighini M, Magagnoli C, Pizza M, et al. Common features of the NAD-binding and catalytic site of ADP-ribosylating toxins. Mol Microbiol 1994;14:41-50.
14. Stein PE, Boodhoo A, Amstrong GD, et al. The crystal structure of pertussis toxin. Structure 1994;2:45-57.
15. Rappuoli R, Pizza M. Novel molecular biology approaches to acellular vaccines. Biotechnol Annu Rev 1996;2:391-408.
16. Sato H, Sato Y. Relationship between structure and biological and protective activities of pertussis toxin. Dev Biol Stand 1991;73:121-32.
17. Sato H, Sato Y. Bordetella pertussis infection in mice: correlation of specific antibodies against two antigens, pertussis toxin, and filamentous hemagglutinin with mouse protectivity in an intracerebral or aerosol challenge system. Infect Immun 1984;46:415-21.
18. Robbins JB, Pittman M, Trollfors B, et al. Primum non nocere: a pharmacologically inert pertussis toxoid alone should be the next pertussis vaccine. Pediatr Infect Dis J 1993;12:795-807.